108 related articles for article (PubMed ID: 17182888)
1. An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor.
McDonald NA; Henstridge CM; Connolly CN; Irving AJ
Mol Pharmacol; 2007 Apr; 71(4):976-84. PubMed ID: 17182888
[TBL] [Abstract][Full Text] [Related]
2. The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro.
Vitalis T; Lainé J; Simon A; Roland A; Leterrier C; Lenkei Z
Eur J Neurosci; 2008 Nov; 28(9):1705-18. PubMed ID: 18973587
[TBL] [Abstract][Full Text] [Related]
3. CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons.
Nyíri G; Cserép C; Szabadits E; Mackie K; Freund TF
Neuroscience; 2005; 136(3):811-22. PubMed ID: 16344153
[TBL] [Abstract][Full Text] [Related]
4. Generation and functional characterization of fluorescent, N-terminally tagged CB1 receptor chimeras for live-cell imaging.
McDonald NA; Henstridge CM; Connolly CN; Irving AJ
Mol Cell Neurosci; 2007 Jun; 35(2):237-48. PubMed ID: 17467290
[TBL] [Abstract][Full Text] [Related]
5. Constitutive trafficking--more than just running in circles?
Bohn LM
Mol Pharmacol; 2007 Apr; 71(4):957-8. PubMed ID: 17251327
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors.
Leterrier C; Lainé J; Darmon M; Boudin H; Rossier J; Lenkei Z
J Neurosci; 2006 Mar; 26(12):3141-53. PubMed ID: 16554465
[TBL] [Abstract][Full Text] [Related]
7. The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons.
Lau T; Schloss P
Eur J Pharmacol; 2008 Jan; 578(2-3):137-41. PubMed ID: 17931621
[TBL] [Abstract][Full Text] [Related]
8. Axonal targeting of the 5-HT1B serotonin receptor relies on structure-specific constitutive activation.
Carrel D; Simon A; Emerit MB; Rivals I; Leterrier C; Biard M; Hamon M; Darmon M; Lenkei Z
Traffic; 2011 Nov; 12(11):1501-20. PubMed ID: 21801291
[TBL] [Abstract][Full Text] [Related]
9. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: evidence for a role of these receptors in axonal growth and guidance.
Gómez M; Hernández ML; Pazos MR; Tolón RM; Romero J; Fernández-Ruiz J
Neuroscience; 2008 May; 153(3):687-99. PubMed ID: 18400407
[TBL] [Abstract][Full Text] [Related]
10. GABAB and CB1 cannabinoid receptor expression identifies two types of septal cholinergic neurons.
Nyíri G; Szabadits E; Cserép C; Mackie K; Shigemoto R; Freund TF
Eur J Neurosci; 2005 Jun; 21(11):3034-42. PubMed ID: 15978014
[TBL] [Abstract][Full Text] [Related]
11. Axonal targeting of Caspr2 in hippocampal neurons via selective somatodendritic endocytosis.
Bel C; Oguievetskaia K; Pitaval C; Goutebroze L; Faivre-Sarrailh C
J Cell Sci; 2009 Sep; 122(Pt 18):3403-13. PubMed ID: 19706678
[TBL] [Abstract][Full Text] [Related]
12. Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface.
Simon AC; Loverdo C; Gaffuri AL; Urbanski M; Ladarre D; Carrel D; Rivals I; Leterrier C; Benichou O; Dournaud P; Szabo B; Voituriez R; Lenkei Z
J Mol Cell Biol; 2013 Aug; 5(4):250-65. PubMed ID: 23585691
[TBL] [Abstract][Full Text] [Related]
13. Differential appearance of dynamin in constitutive and regulated exo-endocytosis: a single-cell multiplex RT-PCR study.
Grabs D; Bergmann M
Cell Tissue Res; 2005 Nov; 322(2):237-44. PubMed ID: 16028072
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
Allen KL; Waldvogel HJ; Glass M; Faull RL
J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
[TBL] [Abstract][Full Text] [Related]
15. Increase of cannabinoid CB1 receptor density in the hippocampus of streptozotocin-induced diabetic rats.
Duarte JM; Nogueira C; Mackie K; Oliveira CR; Cunha RA; Köfalvi A
Exp Neurol; 2007 Mar; 204(1):479-84. PubMed ID: 17222407
[TBL] [Abstract][Full Text] [Related]
16. The T1 domain of Kv1.3 mediates intracellular targeting to axons.
Rivera JF; Chu PJ; Arnold DB
Eur J Neurosci; 2005 Oct; 22(8):1853-62. PubMed ID: 16262625
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid signalling in the enteric nervous system.
Galligan JJ
Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
[TBL] [Abstract][Full Text] [Related]
18. KIF21A-mediated axonal transport and selective endocytosis underlie the polarized targeting of NCKX2.
Lee KH; Lee JS; Lee D; Seog DH; Lytton J; Ho WK; Lee SH
J Neurosci; 2012 Mar; 32(12):4102-17. PubMed ID: 22442075
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
